Overview

Based on interviews with successful biotech entrepreneurs and high-level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment. A must-have for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry.

Full Product Details

Author:   Alexandra Carina Gruber
Publisher:   Wiley-VCH Verlag GmbH
Imprint:   Wiley-VCH Verlag GmbH
Dimensions:   Width: 17.50cm , Height: 1.60cm , Length: 24.60cm
Weight:   0.548kg
ISBN:  

9783527324354

ISBN 10:   3527324356
Pages:   210
Publication Date:   14 January 2009
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

INTRODUCTION Development of the Private Equity and Venture Capital Market Development of the Biotech Industry METHODOLOGY Formulating the Research Goal Conducting the Study Evaluating the Results DATA ANALYSIS AND INTERPRETATION OF RESULTS Description of Interview Partners Major Characteristics of an Entrepreneur Major Characteristics of a Venture Capitalist The Most Important Partnering Criteria Financing Models Biotech Research Areas Alliances and Funding in the Early Stage Alliances and Funding in the Late Stage Exit Routes Primary Causes of Failure Best-practice Countries for Funding Biotech Start-ups Striking Differences between the US and European Venture Capital Markets BIOTECH CASE STUDIES AUSTRIANOVA Biomanufacturing AG AVIR Green Hills Biotechnology AG EUCODIS GmbH Intercell AG onepharm Research & Development GmbH SUMMARY AND CONCLUSIONS The Challenge: When Science Meets Business Checklists Final Observations OUTLOOK AND RECOMMENDATIONS EPILOGUE REFERENCES APPENDICES

Reviews

"""Gruber has become a veteran of marketing and business development in the pharmaceutical industry around the world, specializing in marketing and licensing biotechnological and generic products. She conducted qualitative interviews with entrepreneurs, venture capitalists, and other investors about the interpersonal and financial aspects of starting a biotech company, and presents the results here. By describing the characteristics beliefs, and expectations of each of the groups, she hopes to help investors and entrepreneurs build relationships based on mutual understanding that will lead to greater success in the biotech business, and most especially European companies in competition with American ones."" (SciTech Book News, December 2010)"

Gruber has become a veteran of marketing and business development in the pharmaceutical industry around the world, specializing in marketing and licensing biotechnological and generic products. She conducted qualitative interviews with entrepreneurs, venture capitalists, and other investors about the interpersonal and financial aspects of starting a biotech company, and presents the results here. By describing the characteristics beliefs, and expectations of each of the groups, she hopes to help investors and entrepreneurs build relationships based on mutual understanding that will lead to greater success in the biotech business, and most especially European companies in competition with American ones. (SciTech Book News, December 2010)

Author Information

Alexandra Carina Gruber, born in 1971 in Vienna, Austria, has been working in the pharmaceutical industry for the past 12 years, where she has held various marketing and business development positions and developed a profound expertise in the marketing and licensing of biotech and generic products. She is currently Director of Business Development & Marketing at BIOCRATES Life Sciences in Innsbruck Austria.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions